You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Sign In
Santen Pharmaceutical Co., Ltd.
Home
Contact
A
A
A
Text Size
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Ireland
About Santen
Therapeutic Areas & Products
Media & Investors
Currently selected
Research & Development
Careers
Partnership
Social Responsibility
Media & Investors
Santen
>
Ireland
>
Media & Investors
>
News
Media & Investors
News
Currently selected
Material Bank
Investors
Contact
Santen Pharmaceutical welcomes your enquiries and opinions
Contact
News
Page Image
Page Content
07.10.2016
Santen, RIKEN and FBRI Announce Research Collaboration to Develop New Retinal Disease Treatments
03.08.2016
Santen and University College London to collaborate on ophthalmic research and education
11.05.2016
Vekacia® (Ciclosporin 1mg/mL Eye Drops) Pivotal Trial Meets Primary and Key Secondary Endpoints
11.05.2016
Santen Reports Fiscal 2015 Consolidated Performance
04.11.2015
NICE recommends the use of IKERVIS® in England for the treatment of severe keratitis in adult patients with dry eye disease